FDA seeks to improve MedWatch in wake of painkiller problems

05/17/2005 | Reuters

The FDA plans to hold a two-day meeting beginning tomorrow to discuss ways to improve its MedWatch system to monitor side effects of drugs the agency has approved. The meeting became more significant in the wake of the withdrawal of major drugs from the market because of associated heart risks, leading to criticism of the FDA's handling of their approval.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY